THE TIME IS NOW FOR EUROPEAN HTA: HOW WILL THE EVOLUTION OF EUROPEAN HTA IMPACT ACCESS TO INNOVATIVE MEDICINES?

被引：0
|
作者：
Laisne, E. [1 ]
Allen, N. [1 ]
Kolotourou, K. [1 ]
Sattler-Ermacora, P. [1 ]
Grosvenor, A. [1 ]
机构：
[1] Precis Xtract, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP301
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [41] Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level
    Calabro, G. E.
    La Torre, G.
    de Waure, C.
    Villari, P.
    Federici, A.
    Ricciardi, W.
    Specchia, M. L.
    [J]. BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [42] A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
    Allen, Nicola
    Liberti, Lawrence
    Walker, Stuart R.
    Salek, Sam
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [43] THE METHODOLOGICAL DIFFERENCES OF EUROPEAN JOINT ASSESSMENT AND GERMAN HTA: AN EMPIRICAL APPROACH
    Panni, T.
    Thiele, A.
    Carls, A.
    Wallstab, A.
    Eberle, K.
    Schleibner, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S197 - S198
  • [44] THE ITALIAN HEALTHCARE SYSTEM COMPETENCES IN VIEW OF THE NEW EUROPEAN HTA REGULATION
    Belfiore, M.
    Cavazzani, V
    Chinelli, M.
    Laimeche, M.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S332 - S332
  • [45] HTA of medical devices: Challenges and ideas for the future from a European perspective
    Fuchs, Sabine
    Olberg, Britta
    Panteli, Dimitra
    Perleth, Matthias
    Busse, Reinhard
    [J]. HEALTH POLICY, 2017, 121 (03) : 215 - 229
  • [46] The introduction of Health Technology Assessment (HTA) in Greece and comparison with the European experience
    Mentis, I
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2022, 39 (03): : 313 - 321
  • [47] ROLE OF PROGRESSION FREE SURVIVAL IN THE APPROVAL PROCESS AND EUROPEAN HTA ASSESSMENTS
    Kirchmann, T.
    Deichmann, A.
    Schoenermark, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S19 - S19
  • [48] European Technology Platform on Innovative Medicines
    Donnelly, Fergal
    Jehenson, Philippe
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL MEDICINE, 2005, 19 (03): : 153 - 161
  • [49] ANALYSIS OF HTA PROCESS ON THE BASIS OF PHARMACOECONOMIC GUIDELINES IN CENTRAL EASTERN EUROPEAN COUNTRIES
    Sidzhimova, D.
    Benisheva, T.
    Boncheva, E.
    Trendafilova, P.
    Kralimarkov, N.
    [J]. VALUE IN HEALTH, 2018, 21 : S205 - S205
  • [50] SIMILARITIES AND DIFFERENCES IN EUROPEAN HTA EVIDENCE REQUIREMENTS: ONE FOR ALL OR ONE FOR NONE?
    Mordin, M.
    Fernandez, M. M.
    Pearson, I
    Copley-Merriman, C.
    McBride, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S7 - S7
12345